Association between vascular aging and cardiovascular-kidney-metabolic syndrome

Shuyi Zeng1, Henghua Cui1, Wang Liao1

  • 1Department of Cardiology, The First People's Hospital of Yulin, the Sixth Affiliated Hospital of Guangxi Medical University, Yulin, China.

Frontiers in Endocrinology
|December 12, 2025
PubMed

Insights

Elevated estimated pulse wave velocity (ePWV) is linked to higher Cardiovascular-Kidney-Metabolic syndrome (CKM) risk, especially in young adults. This highlights ePWV as a key marker for CKM progression and cardiovascular disease risk.

Area of Science:

  • Cardiology
  • Nephrology
  • Metabolic Diseases

Background:

  • Cardiovascular-Kidney-Metabolic syndrome (CKM) involves complex interactions between metabolic factors, chronic kidney disease (CKD), and cardiovascular health.
  • CKM increases susceptibility to organ dysfunction and adverse cardiovascular events.
  • Reliable markers are crucial for effective CKM management.

Purpose of the Study:

  • To investigate the association between estimated pulse wave velocity (ePWV) and mortality and prognosis in patients with CKM.
  • To assess ePWV as a potential biomarker for CKM progression and cardiovascular risk.

Main Methods:

  • Analysis of 14,372 participants from the National Health and Nutrition Examination Survey (NHANES) (2005-2018).
  • Utilized weighted logistic regression and Cox proportional hazards models to examine the relationship between ePWV and CKM risk.
  • Employed bootstrap sampling for mediation analysis of the Triglyceride-Glucose (TyG) index and external validation using a separate cohort.

Main Results:

  • A nonlinear positive association was found between ePWV and CKM (P < 0.01), most pronounced in young adults (20-40 years).
  • Higher ePWV was significantly associated with worse survival rates.
  • The TyG index mediated 25.23% of the ePWV-CKM association; an ePWV threshold of 8.52 for CKM Stage 4 was validated.

Conclusions:

  • Elevated ePWV is nonlinearly associated with increased CKM risk, particularly in younger populations.
  • ePWV serves as a valuable indicator for arterial stiffness and CKM progression.
  • Findings offer insights for managing arterial stiffness and preventing early cardiovascular disease in high-risk individuals.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
522
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
541
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
704
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
3.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
217
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K